E-course: Adverse events and toxicity management in the treatment of mPCa patients from an MDT perspective
Organised by the European School of Urology and the EAU Section of Oncological Urology, this e-course aims to educate healthcare professionals (HCPs) on managing adverse events and toxicity in metastatic prostate cancer (mPCa) treatment.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 60 minutes |
The e-course will focus on strengthening the HCPs’ understanding of commonly-faced adverse events and their early detection, improving toxicity management strategies through discussion and case studies, and promoting the importance of a multidisciplinary team (MDT) approach for coordinated care.
E-course aims to enhance the ability of HCPs to handle adverse events and toxicity in mPCa treatment, thereby enhancing patient outcomes through collaborative, informed, and patient-centred approaches.
Speakers:
- Dr. A. Pinto (ES)
- Dr. G. Gandaglia (IT)
This recording is brought to you in collaboration with EAU Section of Oncological Urology.
Acknowledgment
This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.